FDA-approved Trofinetide for Rett Syndrome
What is Trofinetide? Trofinetide is a synthetic glycine-proline-glutamic acid (GPE) tripeptide analogue derived from the N-terminal sequence of insulin-like growth factor 1 (IGF-1). It is primarily…
Read the full articleYou might also wanna read
Novartis Postdoctoral Fellowship: Machine Learning for Chemical Synthesis and Reactivity Prediction
novartis.com·6d ago
Anthropic Launches Claude Science Platform, Entering AI Drug Discovery Race Against DeepMind and OpenAI
awesomeagents.ai·7d ago
Deep-learning platform GPS enables de novo drug discovery by predicting transcriptomic perturbations from chemical structures
cell.com·9d ago
Computational Biologist Eleanor Howe Delivers Candid Assessment of Drug Discovery's Digital Transformation at Bio-IT World 2026
bio-itworld.com·15d ago
AI Drug Discovery Stalled by Lack of Trustworthy Biological Data
the-scientist.com·17d ago
DeepCYP: A deep learning web server for predicting CYP450 drug metabolism pathways
doi.org·18d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.